LivaNova Welcomes New Director

LivaNova PLC has appointed Susan Podlogar to its Board of Directors. She will serve on the Compensation and Human Capital Management Committee.

“LivaNova’s Board of Directors is pleased to welcome Susan Podlogar,” LivaNova Board Chairman William Kozy said. “Susan is a visionary leader with three decades of experience in leading business, talent, and cultural transformations at recognized global companies. She possesses a sharp understanding of the ever-changing global business landscape and will be a tremendous asset to the board.”

Podlogar’s career spans 30 years; she has held key global leadership positions in the consulting, scientific, and financial sectors. Most recently, she was executive vice president, chief Human Resources officer at MetLife from July 2017 until her retirement in June 2024. Prior to MetLife, Podlogar spent 16 years at Johnson & Johnson in various leadership roles, including: global head, Human Resources Medical Devices; global head of Total Rewards and head of Human Resources for Europe, the Middle East, and Africa; and global head, Human Resources and Communications Pharmaceutical R&D. Early career highlights include positions with Bayer Pharmaceutical, Bristol-Myers Squibb, and William M. Mercer.

Podlogar earned an MBA from the University of South Florida and a bachelor’s degree from the University of Wisconsin-Parkside.

“What an honor to join the Board for LivaNova, knowing the company’s life-changing medical technologies advance the quality of life for patients around the world,” Podlogar stated. “I look forward to using my experiences to help LivaNova deepen the commitment to patients and customers, while driving value for the shareholders.”

LivaNova’s board now has 10 directors.

LivaNova is a global medical technology company built on nearly five decades of experience and a commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in London, LivaNova employs approximately 2,900 workers and has a presence in more than 100 countries.